<?xml version="1.0" encoding="UTF-8"?>
<p>This experiment is implemented as the randomized clinical study which will be conducted from December 2020 to October 2021. After obtained approval from the Ethics Committee of People's Hospital of Chengyang District (03982790), we registered it in research registry (researchregistry6243). This study includes 90 patients with advanced lung cancer. With the use of the random number table, all patients will be assigned the random number, and the distribution results will be hidden in the random envelope. All the patients are randomly assigned to the control and intervention group, each group is assigned 45 patients.</p>
